Nishith Desai Associates

Locations

First Exclusive Marketing Rights granted to Indian Pharmaceutical Company

09-25-2003

Should Phase 1 Trials be permitted in India? - Debate continues

11-15-2003

In Pipeline: New Drug policy

08-12-2005

Destination India: Fastest growing Asian hub for clinical trials

10-14-2005

New Bill to regulate scientific research on humans

12-15-2005

Guidelines for Medical Devices notified as "Drugs"

03-02-2006

Recent Mumbai High Court Rulings on Drug Regulations

05-11-2006

Mashelkar Committee submits its report on patentability of NCE's and micro-organisms

01-18-2007

Government contemplating to allow Phase I trials in India

08-09-2007

Novartis' Challenge To Section 3(d) Of Patents Act Dismissed

08-10-2007

Patentee to be heard in proceedings for compulsory licensing for export

07-08-2008

Pay To Participants For Research Related Injuries- Suggests ICMR

11-26-2008

Clinical Trials - Added Stringent Measures On Their Way!

04-22-2009

Phase I trials for drugs discovered outside India take a backseat yet again

05-15-2009

Revised Mashelkar Committee Report on Patent Law Issues accepted by the Government

08-25-2009

The noose tightens around adulterated and spurious drugs players

08-27-2009

Probiotic foods market in India soon to be regulated

12-26-2009

Indian drug authorities to now visit and inspect foreign manufacturers' facilities

01-14-2011

Pharma Regulatory Update 2010

02-08-2011

Clinical Trial Related Information Exempted from Disclosure

06-16-2011